Experienced drug discovery leader with 23 years lead discovery and optimization across a wide range of therapeutic areas and target classes. Significant contributions to the discovery of dozens of leads and 15 pre-clinical candidates, of which so far 8 progressed to IND and 6 to Phase 2 trials. A motivational and empowering leader who thrives on challenges, highly values innovation, and delivers with integrity.